Videos

How an Advocate Unites Voices to Guide MPN Research Decisions

April 28th 2025, 1:00pm

Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.

Crafting an Individual Treatment Plan for Patients With Prostate Cancer

April 26th 2025, 2:00pm

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.

Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care

April 25th 2025, 8:00pm

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemotherapy.

Working to Address Unmet Medical Needs in MPNs

April 24th 2025, 8:00pm

CURE spoke with John Crispino, the director of the division of experimental hematology at St. Jude Children’s Research Hospital.

How to Best Navigate a Diagnosis of Lung and Head and Neck Cancer

April 23rd 2025, 8:00pm

Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.

Joy Anderson Reflects on Her Diagnosis of a Rare Blood Cancer

April 23rd 2025, 7:00pm

A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.

Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T

April 22nd 2025, 8:00pm

Overcoming Barriers to Emotional and Physical Support in Cancer Care

April 22nd 2025, 7:00pm

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.

Raising Awareness for Adolescents and Young Adults with Cancer

April 21st 2025, 8:00pm

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes

April 20th 2025, 2:00pm

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.